申请人:Lizos Dimitrios
公开号:US20100204235A1
公开(公告)日:2010-08-12
Compounds of formula I
in free or salt or solvate form, where R
1
, R
2
and R
5
have the meanings as indicated in the specification, are useful for treating diseases mediated by the ALK-
5
and/or ALK-
4
receptor. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
公式I的化合物,以自由形式、盐形式或溶剂合物形式存在,其中R1、R2和R5的含义如规范中所示,可用于治疗由ALK-5和/或ALK-4受体介导的疾病。还描述了含有这些化合物的药物组合物以及制备这些化合物的方法。